FinancialBuzz.com’s latest Buzz on the Street Show: Featuring Our Corporate News Recap on “NewLeaf Brands’ Wholly Owned Subsidiary We Are Kured, LLC Successfully Manufactures and Fulfills its First Large White Labeled Pen Order for its Client Denver Marketing Co, LLC.”
NewLeaf Brands Inc.’s (CSE: NLB) (OTC: NLBIF) (FSE: 0NF) wholly owned subsidiary We Are Kured, LLC (“Kured”) announces that it has successfully manufactured and fulfilled its first large shipment of its white labeled 500mg disposable vaporizer pens for its client, Denver Marketing Co, LLC.
NewLeaf Brands, Inc. is an innovative Cannabidiol lifestyle Company. Through the Company’s wholly-owned subsidiaries We are Kured, LLC, Drink Fresh Water, LLC, ReLyfe Brand, LLC and TeaLief Brand, LLC the Company’s main business activities encompass the development, marketing, and distribution of CBD products (including vaporizer pens/cartridges, hot/cold tea, softgel capsules and beverages) throughout North America, South America, and Europe. In addition, NewLeaf Brands, Inc. has extensive retail and cultivation land investments in Oregon, USA.
Cannabidiol or CBD has become the latest trend among health and fitness enthusiasts because of its versatility. Over the past several years, extensive research has linked CBD to providing users with various therapeutic benefits, as well as an array of vital nutrients and vitamins. Generally, most people associate CBD with its marijuana counterpart, however, CBD is the active compound found within the hemp plant, which falls under the cannabis family. Similarly, marijuana also falls under the cannabis family, however, its active compound is THC or tetrahydrocannabinol, which is known to induce mind-altering effects on consumers. Nonetheless, researchers have noted that both hemp and marijuana provide similar medical benefits. But despite the similarities, federal regulators are more inclined to approve CBD use because it doesn’t induce psychoactive effects. As a result, many countries began to adopt CBD legislation, which allowed the commercialization of hemp-derived CBD products for medical purposes. Specifically, most countries had stated that CBD products must contain approximately 0.3% THC levels or less to be sold. Notably, countries such as the U.S., Canada, Germany, the U.K., Australia, and New Zealand began to adopt CBD products for medical applications. Moreover, the U.S. and Canada have both legalized CBD products for recreational use as well. In particular, most recreational consumers are purchasing CBD products to simply relax. Overall, the growing demand is leading to a global green rush for CBD products in both the recreational and medical markets. And according to data compiled by Acumen Research and Consulting, the global cannabidiol market is projected to reach USD 22 Billion by 2026 while exhibiting a CAGR of 33% over the forecast period from 2019 to 2026.
CBD is currently being marketed as an all-natural health and wellness solution to medical ailments. In moderate doses, CBD is known to improve overall mood. In higher doses, CBD can induce sleepiness or drowsiness. On the other hand, low doses of CBD can stimulate alertness. Typically, medical practitioners who are eligible to prescribe CBD recommend patients take CBD-based capsules or oils. Specifically, oils are much more popular because of their immediate delivery and potency. However, with the growth of the CBD marketplace, innovators have begun to introduce new products such as tinctures, patches, topicals, edibles, beverages, and even pet foods. As such, the emergence of new products has introduced multiple ways to consume CBD aside from the common method of smoking or vaping. Generally, most consumers taking CBD for medical purposes are looking to alleviate chronic pain issues. However, CBD can provide many more benefits, in addition to pain relief. According to Vaping360, CBD has beneficial effects on major parts of the body such as the brain, eyes, stomach, heart, and intestines. Notably, CBD can act as an antidepressant and antioxidant on the brain. Additionally, CBD can also reduce anxiety levels. As for the heart, CBD works as an anti-inflammatory and anti-ischemic solution, which prevents plaque buildup in the arteries. Despite the beneficial effects of CBD, health officials still believe there is very limited research on the matter. Nonetheless, a multitude of countries have already moved to adopt CBD products and their use. Now, as research continues, more countries are expected to be influenced and ultimately adopt CBD for health and wellness purposes. “Cannabidiol is a popular natural remedy used for many common ailments. Better known as CBD, it is one of over 100 chemical compounds known as cannabinoids found in the cannabis or marijuana plant, Cannabis sativa. Tetrahydrocannabinol (THC) is the main psychoactive cannabinoid found in cannabis, and causes the sensation of getting “high” that’s often associated with marijuana. However, unlike THC, CBD is not psychoactive,” said Jillian Kubala, MS, RD, Registered Dietitian at Hamptons Clinical Nutrition. “This quality makes CBD an appealing option for those who are looking for relief from pain and other symptoms without the mind-altering effects of marijuana or certain pharmaceutical drugs. It’s gaining momentum in the health and wellness world, with some scientific studies confirming it may ease symptoms of ailments like chronic pain and anxiety.”
For more information, please visit: NewLeaf Brands, Inc.
For more corporate news on NewLeaf Brands, Inc., check out the Buzz on the Street
About Buzz on the Street: One of FinancialBuzz.com’s latest corporate and financial news shows, covering the latest trending stock market news. Buzz on the Street looks to become a leader in corporate video news dissemination. Buzz on the Street is 100% original content, brought to you by Financial Buzz Media.